{'fraction_non_alphanumeric': 0.01818181818181818, 'fraction_numerical': 0.004545454545454545, 'mean_word_length': 5.3, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
INTRAUTERINE THERAPY OF INTRAUTERINE GROWTH RESTRICTION

Intrauterine growth restriction (IUGR) is one of the most prevalent causes of fetal mortality and fetal morbidity, affecting up to 10% of all births and it is associated with increased risk of neurological, cardiovascular and metabolic diseases later in life. Even though numerous studies intended to find a therapy for IUGR, no standard therapy for IUGR has been established so far.